Despite the findings from animal studies that carnosine supplementation resulted in improvement in kidney and liver parameters, we did not find any significant effect of carnosine on fibroScan®-related parameters, including median stiffness (hepatic fibrosis), controlled attenuation parameter (CAP) score (hepatic steatosis), and interquartile range to median stiffness (reliability of hepatic stiffness), liver function tests (ALT, GGT, and ALP), and ACR. Here, GPT is linked to fatty liver disease.